Patent Law Weblog
recent posts
- USPTO Moves to Protect Design Rights for Digital Innovations
- Judicial Conduct and Disability Committee Has Its Say, Denies Judge Newman’s Latest Request for Review
- PTAB Issues Judgment on Priority in CRISPR Interference
- Parties File Supplemental Priority Statements in CRISPR Interference
- Why the Alice Test is Stupid, Part V: The Goalposts Keep Moving
about
Month: February 2008
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Apotex Inc. v. Astrazeneca Pharmaceuticals LP et al.8:08-cv-00213; filed January 31, 2007 in the Middle District of Florida Declaratory judgment of non-infringement…
-
By Donald Zuhn –- Last week, we reported on nine letters that were sent to the Senators of eight states between December 12, 2007 and January 29, 2008 by a collection of universities, businesses, and organizations. In the letters, the signatories contend that the Senate’s patent reform bill will harm innovation and result…
-
By Kwame Mensah — Last month, the Director-General of Thailand’s Department of Intellectual Property, Ms. Puangrat Asavapisit, announced that the Thailand National Legislative Assembly had unanimously voted to become a member of the Paris Convention and Patent Cooperation Treaty (PCT). Thailand’s Ministry of Foreign Affairs has now begun legal proceedings on the accession…
-
February 15, 2008 – Patent Claim Construction (Law Seminars International) – Chicago, IL February 25-26, 2008 – Pharma/Biotech Patent Claim Drafting and Prosecution (American Conference Institute) – New York, NY*** February 25-26, 2008 – Strategic Intellectual Property Planning (American Conference Institute) – Scottsdale, AZ March 30-April 1, 2008 – Advanced Courses (Patent Resources Group) –…
-
By Sherri Oslick — Last week, GlaxoSmithKline and Cypress Pharmaceutical filed a joint stipulation of dismissal in their pending lawsuit over generic Zantac® syrup. The suit was filed on June 25, 2007 in the Southern District of New York (see our previous report). Under the terms of the settlement, GSK has agreed not…
Patent Docs 